Loading clinical trials...
Loading clinical trials...
PRECEDE-HF -Prospective, Randomized Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure
Conditions
Interventions
Cardiac Compass with OptiVol Fluid Status Monitoring
Standard of Care alone (clinical assessment)
Locations
33
United States
Anchorage, Alaska, United States
Little Rock, Arkansas, United States
Berkeley, California, United States
Larkspur, California, United States
Colorado Springs, Colorado, United States
Fort Collins, Colorado, United States
Start Date
October 1, 2007
Primary Completion Date
April 1, 2009
Completion Date
April 1, 2009
Last Updated
April 10, 2019
NCT05507879
NCT04551560
NCT07101289
NCT00762333
NCT03994874
NCT04100148
Lead Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions